Development and validation of the Inventory of Depression and Anxiety Symptoms (IDAS)
- PMID: 17845118
- DOI: 10.1037/1040-3590.19.3.253
Development and validation of the Inventory of Depression and Anxiety Symptoms (IDAS)
Abstract
The authors describe a new self-report instrument, the Inventory of Depression and Anxiety Symptoms (IDAS), which was designed to assess specific symptom dimensions of major depression and related anxiety disorders. They created the IDAS by conducting principal factor analyses in 3 large samples (college students, psychiatric patients, community adults); the authors also examined the robustness of its psychometric properties in 5 additional samples (high school students, college students, young adults, postpartum women, psychiatric patients) who were not involved in the scale development process. The IDAS contains 10 specific symptom scales: Suicidality, Lassitude, Insomnia, Appetite Loss, Appetite Gain, Ill Temper, Well-Being, Panic, Social Anxiety, and Traumatic Intrusions. It also includes 2 broader scales: General Depression (which contains items overlapping with several other IDAS scales) and Dysphoria (which does not). The scales (a) are internally consistent, (b) capture the target dimensions well, and (c) define a single underlying factor. They show strong short-term stability and display excellent convergent validity and good discriminant validity in relation to other self-report and interview-based measures of depression and anxiety.
(PsycINFO Database Record (c) 2007 APA, all rights reserved).
Similar articles
-
Further validation of the IDAS: evidence of convergent, discriminant, criterion, and incremental validity.Psychol Assess. 2008 Sep;20(3):248-59. doi: 10.1037/a0012570. Psychol Assess. 2008. PMID: 18778161
-
Development and validation of new anxiety and bipolar symptom scales for an expanded version of the IDAS (the IDAS-II).Assessment. 2012 Dec;19(4):399-420. doi: 10.1177/1073191112449857. Epub 2012 Jul 20. Assessment. 2012. PMID: 22822173
-
[Validation study of the Depressive Experience Questionnaire].Encephale. 2003 Sep-Oct;29(5):445-55. Encephale. 2003. PMID: 14615694 French.
-
Social anxiety and fear of negative evaluation: construct validity of the BFNE-II.J Anxiety Disord. 2007;21(1):131-41. doi: 10.1016/j.janxdis.2006.03.010. Epub 2006 May 3. J Anxiety Disord. 2007. PMID: 16675196
-
Emotional intelligence: Part 1: the development of scales and psychometric testing.Nurs Health Sci. 2009 Mar;11(1):58-63. doi: 10.1111/j.1442-2018.2009.00431.x. Nurs Health Sci. 2009. PMID: 19298310 Review.
Cited by
-
Posttraumatic stress symptoms and cognitive-based smoking processes among trauma-exposed, treatment-seeking smokers: the role of dysphoria.J Addict Med. 2015 Jan-Feb;9(1):68-74. doi: 10.1097/ADM.0000000000000091. J Addict Med. 2015. PMID: 25525942 Free PMC article.
-
Insomnia during the COVID-19 pandemic: the role of depression and COVID-19-related risk factors.Cogn Behav Ther. 2021 May;50(3):246-260. doi: 10.1080/16506073.2021.1879241. Epub 2021 Mar 31. Cogn Behav Ther. 2021. PMID: 33787448 Free PMC article.
-
Psychometric evaluation of the Barriers to Cessation Scale.Psychol Assess. 2017 Jul;29(7):844-856. doi: 10.1037/pas0000379. Epub 2016 Aug 15. Psychol Assess. 2017. PMID: 27736128 Free PMC article.
-
Blunted neural response to rewards as a vulnerability factor for depression: Results from a family study.J Abnorm Psychol. 2015 Nov;124(4):878-89. doi: 10.1037/abn0000081. Epub 2015 Jul 27. J Abnorm Psychol. 2015. PMID: 26214708 Free PMC article.
-
A Neurobiological Profile Underlying Comorbidity Load and Prospective Increases in Dysphoria in a Focal Fear Sample.Biol Psychiatry. 2023 Feb 15;93(4):352-361. doi: 10.1016/j.biopsych.2022.08.009. Epub 2022 Aug 18. Biol Psychiatry. 2023. PMID: 36280453 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical